Endogenous Institutional Change in Favor of Access to Medicines: The Case of Algeria

El-Bahith Review, 2019

9 Pages Posted: 21 Sep 2020

See all articles by Abdelkader Hamadi

Abdelkader Hamadi

Université de Lille

Aimad Datoussaid

Djillali Liabes University of Sidi Bel Abbes

Date Written: 2019

Abstract

Ostrom's (1990) work on natural resources is one of the new models of governance and invites us to take a fresh look at how we think about politics, through which it opened a gap in understanding how individuals and organizations self-organize to collectively reap the benefits of renewable resources. We support the hypothesis that the notion of access to medicines must be considered as a common good in the Algerian health context. It should be carried out within the framework of "Focal Monopoly of Governance" presented by Meisel (2004) and is considered as a potential response to the institutional and political blockages of access to medicines in Algeria. We use the term "Focal Monopoly of Governance" to apply it to the question of access to medicines in Algeria, as a way of overtaking to coordinate the divergent interests between actors. This FMG would be intended to cover the needs of essential medicines under four levers of accessibility: qualitative, legal, economic and geographic.

Keywords: Algeria; Common Good; Change; Access to Medicines

JEL Classification: I10, I18, I28

Suggested Citation

Hamadi, Abdelkader and Datoussaid, Aimad, Endogenous Institutional Change in Favor of Access to Medicines: The Case of Algeria (2019). El-Bahith Review, 2019, Available at SSRN: https://ssrn.com/abstract=3669027

Abdelkader Hamadi

Université de Lille

Cité Scientifique
Villeneuve-d'Ascq, 59650
France

Aimad Datoussaid (Contact Author)

Djillali Liabes University of Sidi Bel Abbes ( email )

B.p N° 89
Sidi Bel Abbes, 22000
Algeria

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
35
Abstract Views
192
PlumX Metrics